By Professor Michael Proinsias Farrell

Reports

Asare-Doku W; Stolk S; Peacock AMY; Shakeshaft A; Waller E; Nathan S; Economidis G; Ravulo J; Meo-Sewabu L; D'Este C; Thapa P; Abbott T; Satour T; Tulele L; Wilson K; Doran C; Mhey-Rivas T; Macpherson G; Lynch M; Taylor S; Santo T; Graham D; Baillie G; Tran A; Aiken A; Harwood E; Turner A; Reeve R; Degenhardt L; Farrell M, 2023, Monitoring and Evaluation of the Kava Pilot Program, National Drug and Alcohol Research Centre, UNSW, Sydney, https://www.odc.gov.au/resources/publications/monitoring-and-evaluation-kava-pilot-program

Sutherland R; Karlsson A; King C; Uporova J; Chandrasena U; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Grigg J; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1qta-pe36, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-ecstasy-and-related-drugs-reporting

Sutherland R; Uporova J; King C; Chandrasena U; Karlsson A; Jones F; Gibbs D; Price O; Dietze P; Lenton S; Salom C; Bruno R; Wilson J; Agramunt S; Daly C; Thomas N; Radke S; Stafford L; Degenhardt L; Farrell M; Peacock A, 2023, Australian Drug Trends 2023: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews., NDARC, Sydney, http://dx.doi.org/10.26190/1tj1-8454, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2023-key-findings-national-illicit-drug-reporting-system-idrs

Shahbazi J; Farrell M; Byrne J; Ali R; Puszka B; Lim XQ; Cook J; Weiss R; Rodgers C; Dunlop A; Lintzeris N; Nielsen S; Grebely J; Zahra E; Degenhardt L; Byrne M, 2023, Considerations for delivering extended-release buprenorphine for opioid dependence in Australia: Preliminary lessons from the Community Long-Acting Buprenorphine (CoLAB) trial, NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2020, RANDWICK, 355, http://dx.doi.org/10.26190/zemp-dx93

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Asare-Doku W; Macdonald C; Ottaviano S; Degenhardt L; Farrell M, 2023, Review of interventions to treat drug use disorders among girls and women in the criminal justice system in low- and middle-income countries, https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_66/ECN72023_CRP10_2304065E.pdf

McKetin R; Thapa P; Uthurralt N; Bo A; Degenhardt L; Farrell M; Mounteney J; Griffiths P; Degan T, 2023, An Overview Of The Evidence For Substance Use Interventions, NDARC, Sydney, http://dx.doi.org/10.26190/yb4b-1c31, https://ndarc.med.unsw.edu.au/resource/overview-evidence-substance-use-interventions

Brothers T; Degenhardt L, 2022, Time periods of altered risk for severe injection drug use-associated skin and soft-tissue infections: protocol for a self-controlled case series in New South Wales, Australia, 2001-2018, UCL Press, http://dx.doi.org/10.14324/000.rp.10157481, http://dx.doi.org/10.14324/000.rp.10157481

Sutherland R; Uporova J; Karlsson A; Price O; Chandrasena U; Swanton R; Gibbs D; Dietze P; Lenton S; Salom C; Grigg J; Wilson Y; Eddy S; Hall C; Daly C; Thomas N; Juckel J; Degenhardt L; Farrell M; Peacock A, 2021, Australian Drug Trends 2021: Key Findings from the National Ecstasy and related Drug Reporting System (EDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/t6sh-g213

Sutherland R; Uporova J; Peacock A; Udesha C; Price O; Karlsson A; Gibbs D; Swanton R; Lenton S; Woods E; Farrell M; Bruno R; Dietze P; Salom C; Thomas N; Daly C; Juckel J; Agramunt S; Wilson Y; Degenhardt L; Moon C, 2021, Australian Drug Trends 2021: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews, NDARC, Sydney, http://dx.doi.org/10.26190/4p6r-jq88

Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5f74257af29e4

Peacock A; Price O; Dietze P; Bruno R; Salom C; Lenton S; Swanton R; Uporova J; Karlsson A; Chan R; Gibbs D; Grigg J; Daly C; Hall C; Wilson T; Degenhardt L; Farrell M, 2020, Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in Australia: Preliminary findings from the Ecstasy and Related Drugs Reporting System 2020, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef1628d8e50c

Chrzanowska A; Gisev N; Price O; Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2020, Tapentadol use and harms in Australia: Analysis of opioid sales data and sentinel survey data from people who inject drugs, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5ef15b883c0ac

Peacock A; Farrell M; Muscat C; Degenhardt L, 2020, Viability of an Early Warning System (ViEWS) study: Final report, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5e586c51e3059

Peacock A; Karlsson T; Uporova J; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da51c1740a16

Peacock A; Uporova J; Karlsson T; Gibbs D; Swanton R; Kelly G; Price O; Bruno R; Dietze P; Lenton S; Salom C; Degenhardt L; Farrell M, 2019, Australian Drug Trends 2019: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5da521d347daf

Gibbs D; Grebely J; Larney S; Butler K; Sutherland R; Starr M; Karlsson A; Uporova J; Degenhardt L; Farrell M; Peacock A, 2019, Self-report and serological HCV status amongst people who inject drugs in NSW and ACT, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin August 2019, http://dx.doi.org/10.26190/5d788a487ac61, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/4.%20DBS%20and%20HCV%20self%20report%20bulletin.pdf

Sutherland R; Memedovic S; Degenhardt L; Farrell M; Peacock A, 2019, Tapentadol use among people who regularly inject drugs in Australia, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/tapentadol-use-among-people-who-regularly-inject-drugs-australia

Peacock A; Gibbs D; Karlsson A; Uporova J; Sutherland R; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Ecstasy and Related Drugs Reporting System (EDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20EDRS%20Interviews%20Method%20and%20Background.pdf

Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson A; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Illicit Drug Reporting System (IDRS) Interviews: Background and Methods, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/National%20IDRS%20Interviews%20Background%20and%20Methods%202018.pdf

Peacock A; Gibbs D; Sutherland R; Uporova J; Karlsson T; Bruno R; Dietze P; Lenton S; Alati R; Degenhardt L; Farrell M, 2018, Australian Drug Trends 2018: Key findings from the National Illicit Drug Reporting System (IDRS) Interviews, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, https://ndarc.med.unsw.edu.au/resource/australian-drug-trends-2018-key-findings-national-illicit-drug-reporting-system-idrs

Back to profile page